Oncolytic Herpes Simplex Virus-Based Therapies for Cancer

With the increased worldwide burden of cancer, including aggressive and resistant cancers, oncolytic virotherapy has emerged as a viable therapeutic option. Oncolytic herpes simplex virus (oHSV) can be genetically engineered to target cancer cells while sparing normal cells. This leads to the direct...

Full description

Bibliographic Details
Published in:	Cells
Main Authors:	Norah Aldrak, Sarah Alsaab, Aliyah Algethami, Deepak Bhere, Hiroaki Wakimoto, Khalid Shah, Mohammad N. Alomary, Nada Zaidan
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Subjects:	oncolytic herpes simplex virus (oHSV) virotherapy immunotherapy cancer
Online Access:	https://www.mdpi.com/2073-4409/10/6/1541

Similar Items

Enhanced therapeutic efficacy for glioblastoma immunotherapy with an oncolytic herpes simplex virus armed with anti-PD-1 antibody and IL-12
by: Lei Wang, et al.
Published: (2024-06-01)

The In Vitro Replication, Spread, and Oncolytic Potential of Finnish Circulating Strains of Herpes Simplex Virus Type 1
by: Kiira Kalke, et al.
Published: (2022-06-01)

Development and Preliminary Application of a Droplet Digital PCR Assay for Quantifying the Oncolytic Herpes Simplex Virus Type 1 in the Clinical-Grade Production
by: Miaomiao Guo, et al.
Published: (2023-01-01)

Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells
by: Kimia Kardani, et al.
Published: (2023-05-01)

Advances in antitumour therapy with oncolytic herpes simplex virus combinations
by: Xuejiao Qi
Published: (2024-07-01)

Development of a novel, high-efficacy oncolytic herpes simplex virus type 1 platform equipped with two distinct retargeting modalities
by: Hyun-Yoo Joo, et al.
Published: (2024-03-01)

The Current Landscape of Oncolytic Herpes Simplex Viruses as Novel Therapies for Brain Malignancies
by: Joshua D. Bernstock, et al.
Published: (2021-06-01)

Oncolytic herpes simplex virus and immunotherapy
by: Wenqing Ma, et al.
Published: (2018-12-01)

Replication and Spread of Oncolytic Herpes Simplex Virus in Solid Tumors
by: Bangxing Hong, et al.
Published: (2022-01-01)

Oncolytic HSV: Underpinnings of Tumor Susceptibility
by: Chase Kangas, et al.
Published: (2021-07-01)

Cell type-specific response of colon cancer tumor cell lines to oncolytic HSV-1 virotherapy in hypoxia
by: Sara Shayan, et al.
Published: (2022-04-01)

Enhancing Therapeutic Efficacy of Oncolytic Herpes Simplex Virus with MEK Inhibitor Trametinib in Some BRAF or KRAS-Mutated Colorectal or Lung Carcinoma Models
by: XuSha Zhou, et al.
Published: (2021-09-01)

The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic Immunotherapy on the Tumor Microenvironment
by: Ifeanyi Kingsley Uche, et al.
Published: (2021-06-01)

Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma
by: Mingming Hu, et al.
Published: (2023-11-01)

Targeting carcinoembryonic antigen-expressing tumors using a novel transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1
by: Dmitry V. Chouljenko, et al.
Published: (2023-03-01)

Enhanced IL-12 transgene expression improves oncolytic viroimmunotherapy
by: Yeaseul Kim, et al.
Published: (2024-06-01)

Biosafety and biohazard considerations of HSV-1–based oncolytic viral immunotherapy
by: Elizabeth Robilotti, et al.
Published: (2023-09-01)

Corrigendum: Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma
by: Mingming Hu, et al.
Published: (2023-12-01)

Triple-Survival Stereotactic Brain Surgeries for the Intracranial Injections of Glioblastoma Stem-like Cells and Oncolytic Herpes Simplex Viruses
by: Sourav Chakraborty, et al.
Published: (2026-05-01)

Histone Deacetylase Inhibitor Panobinostat Benefits the Therapeutic Efficacy of Oncolytic Herpes Simplex Virus Combined with PD-1/PD-L1 Blocking in Glioma and Squamous Cell Carcinoma Models
by: Yinglin Wu, et al.
Published: (2022-12-01)

Herpes simplex eyelid infection
by: Narjisse Taouri, et al.
Published: (2020-07-01)

Direct oHSV Infection Induces DC Maturation and a Tumor Therapeutic Response
by: Doyeon Kim, et al.
Published: (2025-08-01)

Risk of herpes simplex keratitis recurrence after ocular surgeries
by: Piotr Kanclerz, et al.
Published: (2025-06-01)

An oncolytic herpes simplex virus armed with IL-12 for treatment of preclinical glioblastoma
by: Joseph W. Jackson, et al.
Published: (2025-09-01)

Oncolytic herpes simplex virus delivery of dual CAR targets of CD19 and BCMA as well as immunomodulators to enhance therapeutic efficacy in solid tumors combined with CAR T cell therapy
by: Yuanyuan Liu, et al.
Published: (2022-10-01)

Targeting Cancers with oHSV-Based Oncolytic Viral Immunotherapy
by: Rakin Tammam Nasar, et al.
Published: (2024-06-01)

Emerging role of Natural killer cells in oncolytic virotherapy
by: Bhat R, et al.
Published: (2015-03-01)

The Oncolytic herpes simplex virus type-1 (HSV-1) vaccine strain VC2 causes intratumor infiltration of functionally active T cells and inhibition of tumor metastasis and pro-tumor genes VEGF and PDL1 expression in the 4T1/Balb/c mouse model of stage four breast cancer
by: Rafiq Nabi, et al.
Published: (2023-06-01)

Correlation between detergent activity and anti-herpes simplex virus-2 activity of commercially available vaginal gels
by: Andrea Szöllősi, et al.
Published: (2020-01-01)

Single-cell RNA sequencing reveals a strong connection between Gadd45g upregulation and oncolytic HSV infection in tumor tissue
by: Divya Ravirala, et al.
Published: (2021-12-01)

Advances in the Drug Development and Quality Evaluation Principles of Oncolytic Herpes Simplex Virus
by: Basma Eid Abdullah Ghorab, et al.
Published: (2025-04-01)

4-1BBL-Armed Oncolytic Herpes Simplex Virus Exerts Antitumor Effects in Pancreatic Ductal Adenocarcinoma
by: Wenrui Gao, et al.
Published: (2024-11-01)

Navigating herpes simplex encephalitis: Family medicine perspectives from Jharkhand, India
by: Amit Kumar Patel, et al.
Published: (2024-12-01)

Specificity, Safety, Efficacy of EGFRvIII-Retargeted Oncolytic HSV for Xenotransplanted Human Glioblastoma
by: Irene Appolloni, et al.
Published: (2021-08-01)

Herpes simplex virus infection of the central nervous system presenting as a stroke: Case report and review of the literature
by: Fahad AlRashed, et al.
Published: (2025-01-01)

Herpes simplex esophagitis
by: Sameer Bahkali, et al.
Published: (2017-07-01)

Prophylactic Vaccination and Intratumoral Boost with HER2-Expressing Oncolytic Herpes Simplex Virus Induces Robust and Persistent Immune Response against HER2-Positive Tumor Cells
by: Zahid Delwar, et al.
Published: (2023-12-01)

Vaccines against Genital Herpes: Where Are We?
by: Hyeon Cheol Kim, et al.
Published: (2020-07-01)

Tug of war: innate immunity and herpes simplex keratitis
by: Preston Nguyen, et al.
Published: (2025-08-01)

Cutaneous perianal herpes simplex virus infection mimicking condylomata acuminata in a renal transplant recipient: A case report and literature review
by: Nabaa Al‐Zubaidi, et al.
Published: (2024-09-01)